Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

BACKGROUND: Benralizumab can be utilized as add-on biological treatment of severe eosinophilic asthma. However, so far only a few real-life studies have been published with regard to the use of this anti-IL-5 receptor humanized monoclonal antibody. OBJECTIVE: The primary aim of this multicenter obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelaia, Corrado, Crimi, Claudia, Benfante, Alida, Caiaffa, Maria Filomena, Calabrese, Cecilia, Carpagnano, Giovanna Elisiana, Ciotta, Domenico, D’Amato, Maria, Macchia, Luigi, Nolasco, Santi, Pelaia, Girolamo, Pellegrino, Simona, Scichilone, Nicola, Scioscia, Giulia, Spadaro, Giuseppe, Valenti, Giuseppe, Vatrella, Alessandro, Crimi, Nunzio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910091/
https://www.ncbi.nlm.nih.gov/pubmed/33654413
http://dx.doi.org/10.2147/JAA.S297273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910091/
https://www.ncbi.nlm.nih.gov/pubmed/33654413
http://dx.doi.org/10.2147/JAA.S297273

Ejemplares similares